Infection by hepatitis B virus among dentists in Guipúzcoa
García Bengoechea, M.; Cortés, A.; Francisco, C.; Cosme, A.; Arriola, A.; Cabriada, J.; Arenas, J.I.
Medicina Clinica 88(5): 179-181
1987
ISSN/ISBN: 0025-7753 PMID: 3561047 Document Number: 288045
To establsih the prevalence of the infection by hepatitis B virus (HBV) among dentists, the serological markers of that infection were studied in 91 dentists and in 62 dentist assistants from the Guipuzcoa province. Th prevalence of HBV markers was 27,4% among dentists and 9.6% among assistants. A remarkable finding was the increase in the indexes of infection with the years of professional activity, that reached 50% after 20 years in dentists. This findings suggest that immunoprophylaxis with HB vaccine should be recommended in these professionals.
Document emailed within 1 workday
Related Documents
Echeverría, R.F.; Curciarello, J.O.; Basualdo, J.A.; Gómez, J.C.; Corallini, O.; Pérez, C.A.; Picinelli, G.; García, C. 1988: Prevalence of hepatitis B virus infection in dentists of District i of the province of Buenos Aires Acta Gastroenterologica Latinoamericana 18(4): 253-262Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Reuter, G.áb.; Szucs, G.ör. 2004: Is endemic hepatitis e infection present in developed countries?--Accumulating information about the hepatitis e virus and hepatitis e infection Orvosi Hetilap 145(51): 2555-2561
Scheiermann, N.; Kuwert, E.K.; Engelhardt, J.P. 1981: Hepatitis B virus hazard of dentists and dental assistants Deutsche Zahnarztliche Zeitschrift 36(10): 614-618
Meyer, J. 1999: The very low prevalence of hepatitis C infection in Swiss dentists Schweizer Monatsschrift für Zahnmedizin 109(7): 766
Toyoda, H.; Fukuda, Y.; Hayakawa, T. 1997: Hepatitis GB virus C infection in Japanese hemophiliacs with persistent hepatitis C virus infection Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 554-558
Panlilio, A.L.; Shapiro, C.N.; Schable, C.A.; Mendelson, M.H.; Montecalvo, M.A.; Kunches, L.M.; Perry, S.W.; Edwards, J.R.; Srivastava, P.U.; Culver, D.H. 1995: Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group Journal of the American College of Surgeons 180(1): 16-24
Laufer, N.; Cassino, L.; Bolcic, F.; Moretti, F.; Reynoso, R.; Bouzas, M.B.; Cahn, P.; Salomón, H.; Quarleri, J. 2008: Uncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme Journal of Acquired Immune Deficiency Syndromes 49(2): 233-234
Rosenblum, L.; Darrow, W.; Witte, J.; Cohen, J.; French, J.; Gill, P.S.; Potterat, J.; Sikes, K.; Reich, R.; Hadler, S. 1992: Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States JAMA 267(18): 2477-2481
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Chiba, T.; Matsuzaki, Y.; Abei, M.; Shoda, J.; Tanaka, N.; Osuga, T.; Aikawa, T. 1996: The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma American Journal of Gastroenterology 91(6): 1195-1203
Wu, C.S.; Chang, K.Y.; Dunn, P.; Lo, T.H. 1995: Acute hepatitis A with coexistent hepatitis C virus infection presenting as a virus-associated hemophagocytic syndrome: a case report American Journal of Gastroenterology 90(6): 1002-1005
Wang, C-Shan.; Wang, S-Tair.; Chang, T-Tsung.; Yao, W-Jen.; Chou, P. 2002: Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression Archives of Internal Medicine 162(7): 811-815
Meyer, J. 1999: The prevalence of hepatitis C infection among Swiss dentists. the silent epidemic Schweizer Monatsschrift für Zahnmedizin 109(4): 414; 416 439-440
Toussirot, E.; Le Huédé, Gëlle.; Mougin, C.; Balblanc, J-Charles.; Bettinger, D.; Wendling, D. 2002: Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection Journal of Rheumatology 29(11): 2382-2385
Saravanan, S.; Velu, V.; Nandakumar, S.; Madhavan, V.; Shanmugasundaram, U.; Murugavel, K.G.; Balakrishnan, P.; Kumarasamy, N.; Solomon, S.; Thyagarajan, S.P. 2009: Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease Journal of Microbiology Immunology and Infection 42(2): 122-128
Ashkenazi, M.; Fisher, N.; Levin, L.; Littner, M.M. 2009: Seroepidemiology of hepatitis C antibodies among dentists and their self-reported use of infection control measures Community Dental Health 26(2): 99-103
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455